Arcus Capital Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Sell
5,876
-1,657
-22% -$71.2K 0.09% 101
2025
Q4
$330K Buy
7,533
+511
+7% +$21.1K 0.12% 105
2025
Q3
$290K Buy
+7,022
New +$282K 0.13% 95

Other funds holding EXEL

Arcus Capital Partners's EXEL Position: Q1 2026 in Review

Arcus Capital Partners reduced its Exelixis (EXEL) stake by 22% in Q1 2026, selling an estimated $71.2K and leaving 5,876 shares worth $252K. The position accounts for 0.09% of the portfolio, ranked #101.

Arcus Capital Partners first reported a position in EXEL in Q3 2025 and has held it in 3 quarters since. The position peaked at $330K in Q4 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Arcus Capital Partners held 5,876 shares of Exelixis worth $252K as of Q1 2026.
  • Arcus Capital Partners sold 1,657 Exelixis shares in Q1 2026, an estimated $71.2K.
  • Exelixis made up 0.09% of Arcus Capital Partners's portfolio in Q1 2026, its #101 holding.
  • Arcus Capital Partners first reported a position in Exelixis in Q3 2025 and has held it in 3 quarters since.
  • Arcus Capital Partners's Exelixis position peaked at $330K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Arcus Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.